|
HS Code |
309525 |
| Iupac Name | 1-(4,4'-Dichlorobenzhydryl)piperazine |
| Molecular Formula | C17H18Cl2N2 |
| Molecular Weight | 321.25 g/mol |
| Cas Number | 17559-09-6 |
| Appearance | White to off-white solid |
| Melting Point | 120-125°C |
| Solubility | Soluble in DMSO and methanol |
| Purity | Typically >98% |
| Synonyms | 4,4'-Dichlorotriphenylmethylpiperazine |
| Structure Type | Aromatic piperazine derivative |
| Storage Conditions | Store at room temperature, tightly closed |
As an accredited 1-(4,4'-Dichlorobenzhydryl)Piperazine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle, screw cap, 25 grams, labeled with chemical name, structure, CAS number, lot number, and hazard pictograms. |
| Shipping | The chemical 1-(4,4'-Dichlorobenzhydryl)piperazine is shipped in tightly sealed containers to prevent moisture and contamination. It is packed according to safety regulations for hazardous materials, with proper labeling and documentation. Temperature and light exposure controls are observed if required, and all transport complies with national and international chemical shipping guidelines. |
| Storage | Store **1-(4,4'-Dichlorobenzhydryl)Piperazine** in a tightly sealed container in a cool, dry, and well-ventilated area, away from sources of ignition, heat, and incompatible substances such as oxidizing agents. Protect from moisture and direct sunlight. Label the container clearly, and ensure it is kept in a secure chemical storage cabinet dedicated to hazardous or organic compounds. |
Applications of 1-(4,4'-Dichlorobenzhydryl)Piperazine in Industrial ManufacturingAs a primary manufacturer of 1-(4,4'-Dichlorobenzhydryl)Piperazine, we support global industrial producers with high-purity raw material for regulated, large-scale applications. Our products meet strict quality benchmarks required for pharmaceutical and specialty chemical sectors, ensuring customers maintain compliance and process efficiency throughout integration. 1. Antihistamine Active Pharmaceutical Ingredient SynthesisPharmaceutical producers rely on this molecule as a key intermediate in the synthesis of specific first-generation antihistamine APIs, particularly those used for allergic reaction therapies. The downstream route involves direct alkylation and substitution reactions governed by stringent GMP conditions, with batch traceability and impurity controls crucial for regulatory filing. Blending occurs in the intermediate stage before final active ingredient isolation, and manufacturing lines must implement validated cleaning and testing regimes after material introduction. Finished pharmaceutical products often undergo secondary formulation into solid oral dosage forms or injectable solutions distributed under prescription-only regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. CNS-Active Compound Manufacturing for Neurological TreatmentsSpecialty pharmaceutical lines require this raw material in the targeted industrial synthesis of selective central nervous system (CNS) active agents, specifically for anxiolytic and antipsychotic drug candidates where piperazine structures enhance receptor binding properties. Controlled addition at the step involving diarylmethane coupling enables tailored molecular architectures under closed batch reactor conditions monitored by online HPLC. Compliance with international impurity profiling standards remains mandatory, and reactors equip dust and vapour extraction systems to comply with occupational hygiene codes. Downstream formulation partners compound APIs into finished specialty pharmaceutical forms shipped to licensed medical distributors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Process Chemical Use in Industrial Scale Heterocycle SynthesisFine chemical manufacturers utilize this piperazine derivative as a building block for constructing tailored heterocyclic molecules demanded in advanced material science and medicinal chemistry. Production lines feature continuous flow reactors where timed addition optimizes yield of multicyclic end products; operators calibrate the raw material feed based on targeted ring systems and desired electronic properties. Regulatory expectations extend to batch reproducibility and impurity traceability in accordance with ISO-based chemical management standards. Mixing systems limit cross-contamination by enforcing clean-in-place (CIP) validation with recordable batch logs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Research Chemical DevelopmentContract manufacturing organizations (CMOs) and research facilities source 1-(4,4'-Dichlorobenzhydryl)Piperazine for pilot and scale-up runs of innovative molecules targeted for neuropharmacology and advanced receptor mapping studies. Strict inventory control incorporates GHS labeling and proper waste management, and batch records must support traceability from receipt through all experimental syntheses. Small-scale glass reactor setups or parallel reaction blocks receive carefully weighed loads for precision chemistry, and resulting products undergo analytical certification before further use in preclinical studies or patent filings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-(4,4'-Dichlorobenzhydryl)Piperazine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Over time, manufacturing chemicals demands not just technical skill, but also practical insight earned from running production lines year after year. With 1-(4,4'-Dichlorobenzhydryl)Piperazine, every stage matters, starting from the selection of raw materials to the fine-tuning of process parameters and rigorous quality checks. We developed production flows for this compound that don’t just meet agency standards—they reflect the kind of consistency and reliability that generics and larger pharmaceutical firms have come to expect from experienced chemical makers. At each step, our team draws from hands-on knowledge, understanding how raw inputs, temperature profiles, solvent ratios, and humidity affect yield and purity.
We’ve seen the growth in demand from both research and commercial application sectors for intermediates and precursors that require high chemical stability and well-documented traceability. Years of engagement in pharmaceutical supply and specialty manufacturing lineups have shown that shortcuts in upstream processing show up as downstream failures, leading to loss of time, material, and often confidence. Our teams don’t cut corners—every operation gets logged, reviewed, and scrutinized by chemists and technical supervisors who have seen the outcome of both carefully run batches and those that stray from plan.
With 1-(4,4'-Dichlorobenzhydryl)Piperazine, specifications go far beyond a simple assay number. Internal data shows repeated results in purity, minimal content of related impurities, and very tight moisture readings, checked using methods honed across countless manufacturing cycles. Finished product goes through multi-point verification rather than spot checks, including HPLC and GC analysis set by validated protocols.
Lot-to-lot consistency is not a marketing slogan; it’s a lived-in reality that our own teams enforce, since a deviation shows up quickly in processes downstream—either at our customer’s reactors or during application. Control over the chlorination step, careful management of crystal formation, timely removal of byproducts, and meticulous drying pave the way for true batch-to-batch repeatability. Teams with training in applied process chemistry catch issues before they become problems. Documentation from our facilities tracks storage and transit conditions, offering transparency long after the product leaves the gate.
Our history with this compound grew out of direct technical requests from pharmaceutical partners, academic researchers, and developers of specialty ligands. They asked for a piperazine derivative stable in storage, free from residual solvents, and consistently matching defined melting points. We responded with ongoing investments in lab infrastructure, adding precise filtration and temperature-control systems to ensure no surprises for end users.
This compound provides a backbone for projects that go far beyond simple intermediates; it marks a starting point for innovators in medicinal chemistry and materials science. Clients in drug discovery programs rely on its stability profile over long-term storage, noticing fewer degradation products than in earlier variants bought from less rigorous sources. We worked shoulder-to-shoulder with project chemists in scale-up validation, after witnessing the headaches caused by raw material inconsistencies traced to legacy manufacturers.
Technical experts in pilot facilities and production plants have shared valuable first-hand feedback on how minor differences in physical form can affect the usability of piperazine derivatives. Overly friable materials tend to dust, while excessive hardness resists efficient dissolution. Our crushing and sieving protocols strike a careful balance. Finished powder supports fast, reliable charging into reactors, while pelletized options are available for users with specific mechanical needs. Analytical teams routinely check flowability and particle distribution, understanding from years of batch records how these factors shape reaction times, filtration ease, and handling safety.
Direct communication with users often uncovers practical challenges not found in technical bulletins. For instance, avoiding cross-contamination with similar benzhydryl compounds during handling ranked high on the feedback list. Our dedicated lines, with cleaned-in-place equipment, reduce inter-product risk. Feedback from multi-project facilities led us to add detailed in-process cleaning steps and schedule runs to minimize potential for mix-ups.
With its chemical stability and unique piperazine structure, 1-(4,4'-Dichlorobenzhydryl)Piperazine lets formulators develop new chemical entities, stabilize API intermediates, or target specific binding motifs in drug design. As direct suppliers, we’ve addressed questions about solvent carryovers and particle sizing with actual plant measurements, not just theoretical answers.
A crucial difference between our supply and many market alternatives lies in manufacturing depth. We don’t source intermediates from outside vendors or leave crucial steps to third parties. All process development and scale-up occurs in-house, under supervision from staff who have studied the downstream science involved and experienced the problems that arise when product consistency slips.
For customers, this means a steady pipeline not at the mercy of overseas traders, long supply chains, or untraceable intermediates. We produce 1-(4,4'-Dichlorobenzhydryl)Piperazine in dedicated reactors, track every lot in real time with barcoded workflow systems, and apply statistical process controls so deviations are spotted early. We invested in advanced analytical equipment for every shift—our team trusts what comes out of the reactor and verifies with IR, NMR, and chromatographic techniques run by trained operators who know how poor-quality control can cause big losses downstream.
Many new entrants in specialty chemicals might offer a product under the same name. Without deep track records and direct process control, some of them cannot guarantee that unreacted starting materials, residual solvents, or abnormal polymorph formation won’t affect experimental results or pilot plant safety. We have seen clients switch to our product after encountering unexplained out-of-spec downstream reactions or failed stability studies. Years of consistent material supply has built trust with process engineers and project managers, who now factor our production reliability into their R&D planning.
Research teams—both academic and industrial—depend on input materials which won’t break schedules or cause delays. We work directly with users piloting new synthetic pathways, offering flexible pack sizes and custom documentation that includes actual in-process control data and not just finished lot numbers. Our on-site experts advise on storage, shelf life, and help troubleshoot unexpected results that sometimes happen during scale-up or method transfer.
We see the impact when suppliers take accountability for chemical performance. It isn’t enough to provide a list of specifications. Years of working side-by-side with formulation scientists, analytical chemists, and regulatory teams show us how variations in particle size, impurity content, and even packaging type can throw off complex processes. Our facility allows for rapid turnaround of tailored lots for special projects, including scale-up pilots or critical process validation trials—always tracked from raw material to finished product.
By keeping close communication lines with our partners, we help solve bottlenecks and share technical insights to head off issues before they reach production. Our clients keep coming back not for lack of alternatives, but because they get direct access to manufacturing expertise that has lived through multiple product launches, regulatory inspections, and countless process improvements.
Running a specialty chemical plant teaches lessons the hard way. Even minor deviations in temperature, pH, or reaction time in a batch of 1-(4,4'-Dichlorobenzhydryl)Piperazine can shift product purity, color, or physical form. A few ppm of unreacted dichlorobenzhydryl can snowball into project delays. Experienced operators don’t just follow the SOP—they understand the “why” behind every step, seeing the connection between upstream decisions and real-world outcomes in downstream use.
We use process analytical technology to monitor and control runs in real time—years ago, we learned the cost of relying solely on end-of-batch testing. By detecting off-spec trends early, we’re able to intervene and correct, avoiding wasted materials and unnecessary reprocessing.
Safety matters at every stage. Our experience shows that risks related to chlorinated intermediates—whether corrosivity or volatility—are best tackled by overengineering containment and providing ongoing staff training. We invest in automated cleaning, air monitoring, and incident tracking. The payoff is not just regulatory compliance but a record of incident-free lots and genuine peace of mind for the people who work with us.
Working with a variety of piperazine-based compounds, we appreciate that not all structures perform the same way. The 1-(4,4'-Dichlorobenzhydryl) modification delivers unique properties for medicinal and materials researchers. Compared to more common benzhydryl analogues, this compound offers enhanced stability under both thermal and oxidative stress. In practice, this means higher reagent survival through multistep syntheses and fewer side-products in late-stage functionalization.
During customer trials, replacing related derivatives with our product reduced unexpected degradation peaks in both small-scale and scaled-up reactions. Internal process yields improved not just because of purity, but also the consistent particle form that improved mixing and dissolution—details that show up only after handling real materials at the bench or in the plant. Other compounds can introduce more trouble with tackiness, static charge buildup, or inconsistent flow—challenges our technical operators tackled through repeated rounds of real-world process refinement.
By focusing production on a select range of specialty piperazine derivatives, we built up deep practical knowledge. Our lab and plant teams troubleshoot and optimize with data, not assumptions, learning from each run. Clients investing in higher-value downstream products often ask for detailed impurity profiling, forced degradation study results, and physical form data—needs we meet by running the same product through our own advanced application labs.
The value of reliably sourced building blocks like 1-(4,4'-Dichlorobenzhydryl)Piperazine is hard to overstate. Run enough syntheses, or support enough process transfers, and the message becomes clear: a single impurity or missed batch record can halt production or slow regulatory progress. Our internal planning and production controls focus on averting such problems, not just responding to them after the fact.
We invest deliberately in facilities, training, equipment redundancy, and analytical capacity, so bottlenecks in one area don’t cascade into customer disruptions. Our integrated data systems, troubleshooting logs, and years of hands-on maintenance help us spot trends and make smart upgrades well ahead of crisis points.
Every project we support—whether it’s an early-stage research run or a late-phase pharmaceutical scale-up—teaches our team something about how expertise and rigorous practice shape outcomes for our partners. Lessons from past challenges shape our ongoing dedication to manufacturing dependable chemicals that solve real problems for innovators and builders in fields stretching from pharma to cutting-edge materials science.
We don’t see ourselves as just makers of 1-(4,4'-Dichlorobenzhydryl)Piperazine. Our approach centers on helping teams push projects forward, anchored by experience in manufacturing, logistics, process chemistry, and practical troubleshooting. Dedicated experts in our plant field technical questions, troubleshoot challenges, and lend insight gained by seeing thousands of batches through from start to finish.
Many stories from partnerships over the years show how manufacturing expertise creates value. A consistent supply of high-quality intermediates means instrument calibration runs predictably, pilot batches start on time, and downstream processes stay robust. By integrating direct feedback, ongoing training, and investments in technology, we keep raising the bar—not through buzzwords, but through real results in our partners’ projects.
Over decades, hands-on experience and technical discipline have become our most reliable tools. They drive how we develop, produce, and continue to improve 1-(4,4'-Dichlorobenzhydryl)Piperazine. This product embodies our commitment to helping customers do more—quickly, safely, and with confidence in what they’ll get every single time.